(Q35596953)

9 August 2017

title

Increased expression of tumor proliferation genes in Hispanic women with early-stage breast cancer (English)

1 reference

9 August 2017

13

Dawn L Hershman

1 reference

9 August 2017

12

Joseph A Sparano

1 reference

9 August 2017

Kevin Kalinsky

1

1 reference

9 August 2017

Emerson A Lim

2

1 reference

9 August 2017

Eleni Andreopoulou

3

1 reference

9 August 2017

Avni M Desai

4

1 reference

9 August 2017

Zhezhen Jin

5

1 reference

9 August 2017

Yifan Tu

6

1 reference

9 August 2017

Hanina Hibshoosh

7

1 reference

9 August 2017

Antai Wang

8

1 reference

9 August 2017

Heather Greenlee

9

1 reference

9 August 2017

Katherine D Crew

10

1 reference

9 August 2017

Matthew Maurer

11

1 reference

9 August 2017

publication date

25 September 2014

1 reference

9 August 2017

1 reference

9 August 2017

volume

32

1 reference

9 August 2017

issue

9

1 reference

9 August 2017

page(s)

439-444

1 reference

Body mass index, tumor characteristics, and prognosis following diagnosis of early-stage breast cancer in a mammographically screened population

9 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4428554

Expression of aurora kinase A is associated with metastasis-free survival in node-negative breast cancer patients

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4428554

Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4428554

Co-treatment with vorinostat synergistically enhances activity of Aurora kinase inhibitor against human breast cancer cells.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4428554

Therapeutic response to CDK4/6 inhibition in breast cancer defined by ex vivo analyses of human tumors.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4428554

Multiple roles of cyclin-dependent kinase 4/6 inhibitors in cancer therapy

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4428554

Ki 67 is a major, but not the sole determinant of Oncotype Dx recurrence score

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4428554

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4428554

PF-03814735, an orally bioavailable small molecule aurora kinase inhibitor for cancer therapy

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4428554

Ki67 in breast cancer: prognostic and predictive potential

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4428554

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4428554

The obesity epidemic in the United States--gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4428554

BRCA1 phosphorylation by Aurora-A in the regulation of G2 to M transition

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4428554

Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4428554

Cyclins of phases G1, S and G2/M are overexpressed in aneuploid mammary carcinomas

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4428554

Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4428554

Cancer statistics for Hispanics/Latinos, 2012.

27 July 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958232

Differences in breast cancer stage, treatment, and survival by race and ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958232

Disparities in breast cancer characteristics and outcomes by race/ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958232

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958232

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958232

Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with anastrozole or tamoxifen: a TransATAC study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958232

Predictive biomarkers of sensitivity to the aurora and angiogenic kinase inhibitor ENMD-2076 in preclinical breast cancer models.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958232

Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958232

Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958232

Proliferation (Ki-67 and phosphohistone H3) and oncotype DX recurrence score in estrogen receptor-positive breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958232

Ethnic differences in risk and prognostic factors for breast cancer

21 January 2018

1 reference

12 December 2020

Breast cancer survival among New Mexico Hispanic, American Indian, and non-Hispanic white women (1973-1992)

1 reference

12 December 2020

Value of Ki67 in breast cancer: the debate is still open

1 reference

12 December 2020

Clinical Notice for American Society of Clinical Oncology-College of American Pathologists guideline recommendations on ER/PgR and HER2 testing in breast cancer

1 reference

12 December 2020

10.3109/07357907.2014.958232

Identifiers

DOI

1 reference

release_ovkj2kpwlzeqzmlsk5nsqdvhxa

9 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ovkj2kpwlzeqzmlsk5nsqdvhxa

24 November 2022

mapped directly with Wikidata item

PMC publication ID

4428554

1 reference

9 August 2017

1 reference